The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Åke Borg

Åke Borg

Principal investigator

Åke Borg

Activated cell cycle checkpoints in epirubicin-treated breast cancer cells studied by BrdUrd-flow cytometry

Author

  • Ingrid Hedenfalk
  • Bo Baldetorp
  • Åke Borg
  • Stina Oredsson

Summary, in English

Genetic alterations, such as p53 mutations, may affect a tumour's response to chemotherapy. We have treated two human breast cancer cell lines that differ in p53 status with epirubicin in order to study if there are differences in cell cycle kinetic response. MCF-7 cells express wild-type p53, while SK-BR-3 cells express only a mutated form of p53. The transition of cells from one cell cycle stage to another was studied by a bromodeoxyuridine (BrdUrd)-flow cytometry (FCM) method. MCF-7 cells showed a block in the G1 phase after treatment with 50 nM epirubicin for 24 hours, in agreement with the actions of p53 at the G1 checkpoint. SK-BR-3 cells, on the other hand, progressed through the G1 checkpoint and were blocked in late S and G2 phases, presumably due to the activation of a later checkpoint. In addition, studies of the mRNA levels of p53 and its effector gene p21 revealed that although both cell lines expressed p53 mRNA, a marked difference in the mRNA levels of p21 was seen. A dramatic increase in the level of p21 mRNA was seen in epirubicin-treated MCF-7 cells, while no such increase was seen in SK-BR-3 cells.

Department/s

  • Department of Clinical Sciences, Lund
  • Functional zoology

Publishing year

1997

Language

English

Pages

321-327

Publication/Series

Cytometry

Volume

29

Issue

4

Document type

Journal article

Publisher

John Wiley & Sons Inc.

Topic

  • Neurology

Keywords

  • breast cancer
  • epirubicin
  • p21
  • RNA
  • p53
  • bromodeoxyuridine
  • flow cytometry
  • cell cycle kinetics

Status

Published

ISBN/ISSN/Other

  • ISSN: 0196-4763